US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US6869592B1
(en)
|
1998-08-04 |
2005-03-22 |
Diadexus, Inc. |
Method and antibody for imaging lung cancer
|
US6951738B2
(en)
|
1999-07-16 |
2005-10-04 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptors TR13 and TR14
|
EP1292678B8
(en)
*
|
2000-06-16 |
2009-11-04 |
Incyte Corporation |
G-protein coupled receptors
|
EP1174502A1
(en)
*
|
2000-07-18 |
2002-01-23 |
Schering Corporation |
Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
|
US6461855B1
(en)
*
|
2000-09-29 |
2002-10-08 |
Cytokinetics, Inc. |
Motor proteins and methods for their use
|
AU2002224403A1
(en)
*
|
2000-10-13 |
2002-04-22 |
Entremed, Inc |
Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use
|
WO2002050256A2
(en)
|
2000-12-18 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
53010, a human carboxylesterase family member and uses thereof
|
CA2442743A1
(en)
*
|
2001-03-27 |
2002-12-12 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
WO2003006479A1
(en)
*
|
2001-07-13 |
2003-01-23 |
Cogent Neuroscience, Inc. |
Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
|
EP1415997A4
(en)
*
|
2001-07-19 |
2005-03-30 |
Mitsubishi Pharma Corp |
Polypeptides relating to signal transfer of advanced glycation end product receptor
|
EP1430308B1
(en)
*
|
2001-09-24 |
2006-11-22 |
Grünenthal GmbH |
Screening method for different indications using bnpi and/or dnpi
|
US7138370B2
(en)
*
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
ATE364690T1
(en)
|
2001-11-09 |
2007-07-15 |
Proteologics Inc |
POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS
|
CU23225A1
(en)
*
|
2001-12-20 |
2007-08-30 |
Ct Ingenieria Genetica Biotech |
PEPTIDES FOR THE TREATMENT OF CANCER ASSOCIATED WITH HUMAN PAPILOMA VIRUS (HPV) AND OTHER EPITELIAL TUMORS
|
CA2479724A1
(en)
|
2002-03-19 |
2003-10-02 |
Tularik Inc. |
Gene amplification in cancer
|
ATE364096T1
(en)
*
|
2002-03-20 |
2007-06-15 |
Novartis Pharma Gmbh |
METHOD FOR THE DIAGNOSIS AND THERAPY OF SCHIZOPHRENIA
|
EP1361433A3
(en)
*
|
2002-04-09 |
2005-02-23 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
|
IL165364A0
(en)
*
|
2002-05-28 |
2006-01-15 |
Omrix Biopharmaceuticals Inc |
Method for obtaining anti-idiotype antibodies
|
EP1541677A4
(en)
*
|
2002-07-10 |
2007-06-27 |
Takeda Pharmaceutical |
Novel proteins and use thereof
|
WO2004016783A1
(en)
*
|
2002-08-06 |
2004-02-26 |
Genox Research, Inc. |
Method of examining atopic dermatitis
|
WO2004018518A1
(en)
*
|
2002-08-23 |
2004-03-04 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
ES2320443T3
(en)
*
|
2002-09-30 |
2009-05-22 |
Oncotherapy Science, Inc. |
GENES AND POLYPEPTIDES RELATED TO HUMAN PANCREATIC CANCERS.
|
GB0223737D0
(en)
*
|
2002-10-11 |
2002-11-20 |
Plant Bioscience Ltd |
A Promoter from streptomyces coelicolor
|
WO2004035791A1
(en)
*
|
2002-10-15 |
2004-04-29 |
The Horticulture And Food Research Institute Of New Zealand Limited |
Plant alpha farnesene synthase and polynucleotides encoding same
|
CA2505842A1
(en)
*
|
2002-11-12 |
2004-07-15 |
Henri Tiedge |
Translational control by small, non-translatable rnas
|
US7638270B2
(en)
|
2003-01-24 |
2009-12-29 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
|
CA2526878A1
(en)
*
|
2003-04-08 |
2004-10-21 |
Colotech A/S |
A method for detection of colorectal cancer in human samples
|
US7834163B2
(en)
|
2003-06-26 |
2010-11-16 |
Exonhit Therapeutics S.A. |
Prostate specific genes and the use thereof as targets for prostate cancer therapy
|
EP2311468B1
(en)
|
2003-08-08 |
2014-01-15 |
Perseus Proteomics Inc. |
Gene overexpressed in cancer
|
US8010189B2
(en)
|
2004-02-20 |
2011-08-30 |
Brainsgate Ltd. |
SPG stimulation for treating complications of subarachnoid hemorrhage
|
AU2005219839B9
(en)
|
2004-03-01 |
2011-12-22 |
Immune Disease Institute, Inc |
Natural IgM antibodies and inhibitors thereof
|
WO2006013661A1
(en)
*
|
2004-08-05 |
2006-02-09 |
Toagosei Co., Ltd. |
Crohn’s disease antibody epitope peptide and reagent for testing crohn’s disease
|
EP1939286A4
(en)
*
|
2005-07-29 |
2009-05-20 |
Kyowa Hakko Kirin Co Ltd |
Novel peptides
|
IL172297A
(en)
*
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for diagnosis of preeclamsia
|
AU2007211544A1
(en)
*
|
2006-02-01 |
2007-08-09 |
Exonhit Therapeutics Sa |
Methods of treating degenerative disorders with Rac 1b inhibitor
|
WO2007105442A1
(en)
*
|
2006-02-22 |
2007-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Therapeutic agent for food intake disorder or water intake disorder
|
EP2099913B1
(en)
|
2006-12-20 |
2012-02-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions
|
WO2009014450A1
(en)
*
|
2007-07-24 |
2009-01-29 |
Sanare As |
Novel peptides with anti-tumor activity
|
CA2695813A1
(en)
*
|
2007-08-09 |
2009-02-12 |
Novartis Ag |
Thiopeptide precursor protein, gene encoding it and uses thereof
|
GB0803352D0
(en)
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
TW201000115A
(en)
*
|
2008-06-11 |
2010-01-01 |
Oncotherapy Science Inc |
IQGAP3 epitope peptides and vaccines containing the same
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
AU2009313808B2
(en)
|
2008-11-14 |
2013-05-16 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
US9080205B2
(en)
|
2012-03-30 |
2015-07-14 |
The United States of America as represented by the Federal Bureau of Investigation, Department of Justice |
Quantification of human mitochondrial DNA using synthesized DNA standards
|
CN104937100B
(en)
*
|
2012-12-25 |
2020-04-03 |
宝生物工程株式会社 |
AAV variants
|
JP6162319B2
(en)
|
2013-03-12 |
2017-07-12 |
デシミューン セラピューティクス,インコーポレイテッド |
Humanized anti-N2 antibody
|
EP3053592A4
(en)
*
|
2013-10-01 |
2017-09-06 |
Mie University |
T cell-inducing vaccine containing interepitope sequence promoting antigen presentation
|
CA3112427A1
(en)
*
|
2018-10-19 |
2020-04-23 |
The Francis Crick Institute Limited |
Novel cancer antigens and methods
|
WO2021030799A1
(en)
*
|
2019-08-15 |
2021-02-18 |
Cohbar, Inc. |
Therapeutic peptides
|
WO2021030749A1
(en)
*
|
2019-08-15 |
2021-02-18 |
Cohbar, Inc. |
Therapeutic peptides
|
US20220305079A1
(en)
*
|
2019-08-15 |
2022-09-29 |
Cohbar, Inc. |
Therapeutic peptides
|
US20220324925A1
(en)
*
|
2019-08-15 |
2022-10-13 |
Cohbar, Inc. |
Therapeutic peptides
|
EP4352083A1
(en)
*
|
2021-06-11 |
2024-04-17 |
Sorbonne Universite |
Short antimicrobial peptides
|